Sign In
Buy UTRS
$0.0001000000
+0 (+0%)
At Close: Jul 31, 2026
Minerva Surgical, Inc. (UTRS) Q4 2022 Earnings Call Transcript
05:47pm, Tuesday, 21'st Mar 2023
Minerva Surgical, Inc. (NASDAQ:UTRS ) Q4 2022 Earnings Conference Call March 21, 2023 4:30 PM ET Company Participants Caroline Corner - IR Todd Usen - President and CEO Joel Jung - CFO Conference Call
Minerva Surgical to Announce Fourth Quarter and Full Year 2022 Financial Results
04:01pm, Wednesday, 08'th Mar 2023
SANTA CLARA, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today tha
Minerva Surgical to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:01pm, Tuesday, 03'rd Jan 2023
SANTA CLARA, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on the treatment of Abnormal Uterine Bl
Minerva Surgical to Present at the 34th Annual Piper Sandler Healthcare Conference
04:01pm, Monday, 21'st Nov 2022
SANTA CLARA, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that
Minerva Surgical, Inc. (UTRS) Q3 2022 Earnings Call Transcript
10:17pm, Monday, 14'th Nov 2022
Minerva Surgical, Inc. (NASDAQ:UTRS ) Q3 2021 Earning Conference Call November 14, 2022 4:30 PM ET Company Representatives Dave Clapper - President, Chief Executive Officer Joel Jung - Chief Financial
Minerva Surgical Announces Change of Date for Third Quarter 2022 Earnings Release and Conference Call
04:01pm, Monday, 07'th Nov 2022
SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that
Minerva Surgical to Announce Third Quarter 2022 Financial Results
04:01pm, Wednesday, 26'th Oct 2022
SANTA CLARA, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that
Minerva Surgical to Present at the H.C. Wainwright 24th Annual Global Investment Conference
04:01pm, Monday, 29'th Aug 2022
SANTA CLARA, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on the treatment of Abnormal Uterine Bl
Minerva Surgical, Inc. (UTRS) CEO Dave Clapper on Q2 2022 Results - Earnings Call Transcript
01:51pm, Saturday, 13'th Aug 2022
Minerva Surgical, Inc. (NASDAQ:UTRS ) Q2 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants Caroline Corner - Investor Relations Dave Clapper - President and Chief Executive O
Minerva Surgical to Announce Second Quarter 2022 Financial Results
04:01pm, Thursday, 28'th Jul 2022
SANTA CLARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that
